FDA Radiology AI Devices

QP-Prostate® CAD is an artificial intelligence-based software that helps doctors detect and identify suspicious lesions in the prostate gland using bi-parametric prostate MRI. It highlights areas of concern on the images to assist physicians during their interpretation but should be used alongside other clinical information. It seamlessly integrates with existing DICOM imaging systems and PACS, improving the diagnostic workflow for prostate cancer detection.

Prostate MR AI (VA10A) is a plug-in AI software device designed to assist radiologists in interpreting prostate MRI scans. It automatically segments the prostate gland, detects suspicious lesions, and assigns scores to help radiologists identify and classify potential prostate cancer. This tool supports clinicians by augmenting their workflow and improving diagnostic accuracy.

Galen™ Second Read™ is a software tool that analyzes digital images of prostate biopsy slides to identify regions suspicious for prostate cancer. It flags slides initially diagnosed as benign if it detects potential cancer areas, providing pathologists with case-level alerts and heatmaps to assist in further review. This helps improve cancer detection beyond the initial pathology review but is not intended to replace standard pathology diagnosis.

Medihub Prostate is a semi-automatic image processing software designed for analyzing prostate MR images. It uses AI to outline the prostate region semi-automatically and supports radiologists and urologists in reviewing MR data. The software requires user editing and confirmation, enhancing the accuracy of prostate volume measurements and analysis, aiding clinical decision-making without replacing the expert's judgment.

Quantib Prostate is a software tool that helps medical professionals analyze prostate MRI images. It automatically segments the prostate and its subregions, supports visualization with multiparametric MRI, and assists in identifying and editing potential lesions. By streamlining these tasks, it aids radiologists in interpreting prostate MRI studies more efficiently and effectively.

The Avenda Health AI Prostate Cancer Planning Software is an AI-driven tool that assists physicians by segmenting prostate MR images, evaluating and quantifying lesions, and planning diagnostic or interventional procedures such as biopsies or tissue ablation. It provides a cancer probability map and confidence scores to help clinicians accurately characterize prostate cancer lesions, improving workflow efficiency and decision making in prostate cancer care.

ProstatID is an AI software tool designed to assist radiologists by analyzing prostate MRI scans to identify and assess suspicious lesions that may indicate prostate cancer. It processes MRI images and provides detection overlays, lesion likelihood scores, 3D renderings, and a summary report to support diagnostic decisions for high-risk screening or diagnostic imaging.

Quantib Prostate is an AI-powered image post-processing software designed to assist medical professionals in analyzing prostate MRI scans. It provides tools for visualization, semi-automatic segmentation of prostate anatomy and lesions, volume computations, and PI-RADS scoring support to facilitate the interpretation of prostate MR studies, aiding clinical decision-making.

aPROMISE X is a software platform for healthcare professionals and researchers that assists in accepting, transferring, storing, manipulating, quantifying, and reporting digital medical images from PSMA PET/CT scans. It allows users to visualize multiple scans, mark regions of interest, and perform quantitative analysis to help identify suspicious lesions in oncology cases, improving clinical efficiency and consistency.

Paige Prostate is an AI software device by Paige.AI designed to assist pathologists in detecting prostate cancer in digitized pathology slides from needle biopsies. It analyzes whole slide images scanned from H&E stained tissue samples and identifies areas most suspicious for cancer, helping pathologists to focus their review and improve diagnostic accuracy. It serves as an adjunct tool and supports clinicians in making more accurate prostate cancer diagnoses.